Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. The company’s operations are managed on a products basis across four segments, with a focus on the pharmaceutical segment. Merck continues to execute its innovation strategy, with sustained investment in research yielding approvals and regulatory milestones across various therapeutic areas. The company seeks growth opportunities that align with its strategic criteria while remaining financially disciplined. Merck's business development strategy emphasizes identifying external innovations to augment its portfolio and pipeline, particularly focusing on early-to-mid-stage assets. The company’s research efforts are concentrated on therapeutic areas that can significantly impact human health, such as oncology and diabetes. Merck is committed to enhancing its capabilities in digital technologies and information management, which are essential for supporting business strategies and improving operational efficiency. The company emphasizes the importance of mobilizing and deploying IT-based resources in conjunction with leveraging other capabilities to transform into a competitive force. Merck's IT capabilities are crucial for providing data and information to users with appropriate levels of accuracy, timeliness, reliability, security, and confidentiality, tailored to changing business needs. The company’s investment decisions reflect a focus on actionable investments that contribute to long-term growth and sustainable value for shareholders. Merck's strategic collaborations, such as the partnership with Moderna for developing personalized cancer vaccines, illustrate its commitment to leveraging technology capabilities for innovation. Additionally, the company’s focus on productivity improvements and resource allocation is aimed at supporting its strongest brands and promising pipeline assets. Merck's financial performance is influenced by market dynamics, including competition and pricing pressures, which necessitate agile responses to maintain market positioning. The company’s strategic resource allocation and management practices are designed to optimize operational flexibility and enhance organizational capabilities. Merck's ongoing commitment to research and development, along with its strategic management practices, positions the company to navigate the complexities of the health care landscape effectively. The emphasis on digital transformation and IT deployment underscores the importance of technology in driving business innovation and improving firm performance. Overall, Merck's integrated approach to managing its resources and capabilities is fundamental to achieving its organizational goals and sustaining competitive advantage in the global health care market.